There is currently an interest in developing new therapies for HIV-associated malignancies, based on viral, vascular or other pathogenesis-based targets. Cite this: Therapy Insight: AIDS-Related ...

The progression of HIV disease in the setting of vigorous anti-HIV responses remains a central paradox in the pathogenesis of HIV infection. [6,8] Elements of both the humoral and cell-mediated ...

A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered ... "Host genetic and immune factors drive evasion of HIV-1 pathogenesis in viremic non-progressors," published ...